Veda N. Giri, MD

Veda N. Giri, MD is Professor of Medicine at Yale University and is a medical oncologist with specialization in clinical cancer genetics. She serves as Division Chief of Clinical Cancer Genetics for Yale School of Medicine, Director of the Cancer Genetics and Prevention Program, and Director of the Early-Onset Cancer Program at Yale Cancer Center. As leader of Cancer Genetics and Prevention, Dr. Giri leads a comprehensive effort in genetic evaluation for precision medicine, tailored cancer screening, and hereditary cancer assessment across patient populations. She is the Principal Investigator of multiple grant-funded cancer genetic evaluation studies spanning genetic counseling, genetic testing, disparities, behavioral science, and implementation research. As Director of the Early-Onset Cancer Program, Dr. Giri is leading a cutting-edge translational effort to address clinical, research, and psychosocial needs of patients with early-onset cancers. Dr. Giri serves on several national committees including the National Comprehensive Cancer Network, NIH PDQ® Cancer Genetics Editorial Board, and American Society of Clinical Oncology, contributing expertise in cancer genetics at the national level.

Dr. Giri received her medical degree from Sidney Kimmel Medical College (previously Jefferson Medical College) and proceeded to complete her residency in Internal Medicine and fellowship in Hematology-Oncology at the University of Michigan. She then completed advanced training in molecular cancer genetics and cancer risk assessment at Fox Chase Cancer Center. She also has a certification in cancer risk assessment from City of Hope Comprehensive Cancer Center.